TWIST1 and prostate cancer: Collectively, these data suggest that EVs from a proinflammatory environment may exacerbate the malignant phenotype of prostate cancer cells by targeting the TWIST1/EMT signaling axis and that this axis may serve as a potential therapeutic target in highly metastatic cells.